Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain
Open Access
- 26 June 2019
- journal article
- research article
- Published by American Society for Microbiology in mSphere
- Vol. 4 (3) , e00194-19
Abstract
Vivax malaria is the second leading cause of malaria worldwide and the major cause of non-African malaria. Unfortunately, efforts to develop antimalarial vaccines specifically targeting Plasmodium vivax have been largely neglected, and few candidates have progressed into clinical trials. The Duffy binding protein is considered a leading blood-stage vaccine candidate because this ligand’s recognition of the Duffy blood group reticulocyte surface receptor is considered essential for infection. This study identifies a new target epitope on the ligand’s surface that may serve as the target of vaccine-induced binding-inhibitory antibody (BIAb). Understanding the potential targets of vaccine protection will be important for development of an effective vaccine.Keywords
Funding Information
- National Institutes of Health (R01AI064478)
This publication has 80 references indexed in Scilit:
- Conserved and Variant Epitopes of Plasmodium vivax Duffy Binding Protein as Targets of Inhibitory Monoclonal AntibodiesInfection and Immunity, 2012
- Design and Immunogenicity of a Novel Synthetic Antigen Based on the Ligand Domain of the Plasmodium vivax Duffy Binding ProteinClinical and Vaccine Immunology, 2012
- Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARCNature Structural & Molecular Biology, 2011
- Mapping Epitopes of the Plasmodium vivax Duffy Binding Protein with Naturally Acquired Inhibitory AntibodiesInfection and Immunity, 2010
- Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean ChildrenInfection and Immunity, 2009
- Naturally acquired inhibitory antibodies toPlasmodium vivaxDuffy binding protein are short-lived and allele-specific following a single malaria infectionClinical and Experimental Immunology, 2009
- Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infectionProceedings of the National Academy of Sciences, 2008
- Mimotopes of Apical Membrane Antigen 1: Structures of Phage-Derived Peptides Recognized by the Inhibitory Monoclonal Antibody 4G2dc1 and Design of a More Active AnalogueInfection and Immunity, 2007
- Passive Immunization with a Multicomponent Vaccine against Conserved Domains of Apical Membrane Antigen 1 and 235-Kilodalton Rhoptry Proteins Protects Mice againstPlasmodium yoeliiBlood-Stage Challenge InfectionInfection and Immunity, 2006
- The Most Polymorphic Residue on Plasmodium falciparum Apical Membrane Antigen 1 Determines Binding of an Invasion-Inhibitory AntibodyInfection and Immunity, 2006